Skip to main content

Table 3 Utilisation of selected atypical antipsychotics in Austria as a percentage of total atypical antipsychotic use between 2005 and 2010 (defined daily dose basis)

From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Atypical antipsychotic 2005 2006 2007 2008 2009 2010 % Change
Risperidone 31.6 29.9 28.6 26.9 25.5 23.8 -25
Amisulpride 8.4 7.1 6.7 6.3 5.9 5.5 -35
Aripiprazole 2.5 5.4 7.2 9.1 10.6 11.8 376
Olanzapine 36.6 33.3 31.3 29.6 28.0 26.1 -29
Quetiapine 18.6 22.5 24.8 27.0 29.6 32.7 75
Paliperidone 0.00 0.00 0.00 0.02 0.04 0.03 NA
Zotepine 2.2 1.8 1.4 0.9 0.4 0.1  
  1. NA, not applicable.